Who Benefits from the 340B Drug Discount Program?

Allyson Funk   |     June 10, 2015   |   SHARE THIS

340BSpotlight_HeaderThe 340B program was created by Congress in 1992 to help vulnerable or uninsured patients gain access to needed prescription medicines, by requiring pharmaceutical manufacturers to provide steep discounts to certain types of clinics and hospitals as a condition of their drugs being covered by Medicaid.

Watch our new video on 340B


Unfortunately, the program has strayed from its core mission and is growing dramatically, with hospitals responsible for much of this growth. While clinics that receive government grants largely use the program to improve access to medicines for needy patients, not all 340B hospitals are good stewards of the program.

P340BSpotlight_ThumbnailhRMA supports the original intent of the program and is committed to working with Congress and the administration to reform the 340B program to ensure it reaches the vulnerable or uninsured patients it was intended to help.

To learn more about 340B, follow our 340B Spotlight series or sign-up for personalized email updates hereGet Updates

Allyson Funk

Allyson Funk Ally is a former senior director of public affairs at PhRMA focused on advocacy issues for the biopharmaceutical industry. Her expertise includes Medicare, Medicaid, 340B, health reform and more. Prior to PhRMA, her experience included leading health communications for a large membership organization, supporting public affairs clients and working for the governor of Louisiana.

Topics: 340B, Medicaid, Hospitals, 340B Spotlight

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates